Neurobiology of disease

Potential of changing gut bacteria and their short-chain fatty acids to help treat epilepsy

Updated

Abstract

Gut microbiota dysbiosis may play a significant role in epilepsy through the modulation of short-chain fatty acids (SCFAs).

  • Epilepsy is defined by the occurrence of at least two unprovoked seizures more than 24 hours apart.
  • Short-chain fatty acids are produced by gut microbiota and are important for maintaining gut-brain communication.
  • SCFAs help regulate seizures by preserving intestinal barrier integrity and influencing immune responses in the gut.
  • These metabolites also impact the structure and function of the blood-brain barrier and may regulate neuroinflammation.
  • Understanding the relationship between SCFAs and epilepsy could lead to potential new treatments targeting gut microbiota.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free